Enhanced Efficacy of a Codon-Optimized DNA Vaccine Encoding the Glycoprotein Precursor Gene of Lassa Virus in a Guinea Pig Disease Model When Delivered by Dermal Electroporation

Lassa virus (LASV) causes a severe, often fatal, hemorrhagic fever endemic to West Africa. Presently, there are no FDA-licensed medical countermeasures for this disease. In a pilot study, we constructed a DNA vaccine (pLASV-GPC) that expressed the LASV glycoprotein precursor gene (GPC). This plasmid...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Vaccines (Basel)
Main Authors: Cashman, Kathleen A., Broderick, Kate E., Wilkinson, Eric R., Shaia, Carl I., Bell, Todd M., Shurtleff, Amy C., Spik, Kristin W., Badger, Catherine V., Guttieri, Mary C., Sardesai, Niranjan Y., Schmaljohn, Connie S.
Formato: Artigo
Idioma:Inglês
Publicado: MDPI 2013
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4494234/
https://ncbi.nlm.nih.gov/pubmed/26344112
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/vaccines1030262
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares